Leock Y. Ngo

617 total citations
35 papers, 451 citations indexed

About

Leock Y. Ngo is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Leock Y. Ngo has authored 35 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 20 papers in Pediatrics, Perinatology and Child Health and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Leock Y. Ngo's work include Epilepsy research and treatment (21 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neuroscience and Neuropharmacology Research (11 papers). Leock Y. Ngo is often cited by papers focused on Epilepsy research and treatment (21 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neuroscience and Neuropharmacology Research (11 papers). Leock Y. Ngo collaborates with scholars based in United States, United Kingdom and Japan. Leock Y. Ngo's co-authors include Jashvant D. Unadkat, Shivakumar D. Patil, Paul Glue, Anna Patten, Pek Yee Lum, Peter W. Swaan, Cheng Chang, Ronald T. Coutts, Aimée H. Bakken and Manoj Malhotra and has published in prestigious journals such as Neurology, Antimicrobial Agents and Chemotherapy and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Leock Y. Ngo

31 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leock Y. Ngo United States	11	150	126	120	117	96	35	451
Jennifer H. Gray United States	4	78 0.5×	29 0.2×	236 2.0×	44 0.4×	155 1.6×	5	478
Andrea Nagy Hungary	14	131 0.9×	74 0.6×	13 0.1×	43 0.4×	27 0.3×	39	432
Zsuzsanna Hracskó Hungary	11	106 0.7×	23 0.2×	41 0.3×	17 0.1×	54 0.6×	17	505
Launa J. Aspeslet Canada	14	107 0.7×	55 0.4×	33 0.3×	39 0.3×	45 0.5×	24	598
René Bouw United Kingdom	9	94 0.6×	105 0.8×	9 0.1×	33 0.3×	56 0.6×	10	332
Gary N. Y. Chan Canada	10	211 1.4×	23 0.2×	15 0.1×	15 0.1×	316 3.3×	10	665
C. C. P. Aires Portugal	6	275 1.8×	180 1.4×	4 0.0×	25 0.2×	53 0.6×	8	530
J. A. Duley United Kingdom	11	73 0.5×	9 0.1×	93 0.8×	19 0.2×	19 0.2×	25	436
W. Beindl Austria	6	50 0.3×	17 0.1×	50 0.4×	128 1.1×	26 0.3×	7	540
Dymphy Huntjens Belgium	13	58 0.4×	69 0.5×	3 0.0×	73 0.6×	110 1.1×	28	609

Countries citing papers authored by Leock Y. Ngo

Since Specialization

Citations

This map shows the geographic impact of Leock Y. Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leock Y. Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leock Y. Ngo more than expected).

Fields of papers citing papers by Leock Y. Ngo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leock Y. Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leock Y. Ngo. The network helps show where Leock Y. Ngo may publish in the future.

Co-authorship network of co-authors of Leock Y. Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of Leock Y. Ngo. A scholar is included among the top collaborators of Leock Y. Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leock Y. Ngo. Leock Y. Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vossler, David G., Brenda E. Porter, Ryutaro Kira, et al.. (2024). Efficacy and safety of perampanel in patients with seizures associated with Lennox–Gastaut syndrome: A randomized trial. Epilepsia. 66(2). 379–393. 9 indexed citations

Punia, Vineet, et al.. (2024). Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study. Journal of Neurology. 271(7). 4587–4598. 1 indexed citations

Watanabe, Toshihide, et al.. (2023). Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to <12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis. Seizure. 110. 109–116. 3 indexed citations

Hanaya, Ryosuke, Yuichi Kubota, Masahiro Mizobuchi, et al.. (2023). Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy. Epilepsia Open. 8(4). 1369–1382. 2 indexed citations

Porter, Brenda E., Ryutaro Kira, Jeehun Lee, et al.. (2023). Efficacy and safety of perampanel in a randomized, placebo-controlled trial with an open-label extension in patients with seizures associated with Lennox-Gastaut syndrome (LGS). Journal of the Neurological Sciences. 455. 121563–121563. 1 indexed citations

Resnick, Trevor, Anna Patten, Leock Y. Ngo, & Manoj Malhotra. (2022). Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332. Epilepsy & Behavior. 128. 108528–108528. 3 indexed citations

Hussein, Ziad, Oneeb Majid, Peter D. W. Boyd, et al.. (2022). Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study. Clinical Pharmacology in Drug Development. 11(7). 878–888. 7 indexed citations

Trigg, Andrew, Elaine Brohan, Kim Cocks, et al.. (2021). Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel. Epilepsy & Behavior. 118. 107938–107938. 8 indexed citations

Maguire, Melissa, Elinor Ben‐Menachem, Anna Patten, Manoj Malhotra, & Leock Y. Ngo. (2021). A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy. Epilepsy & Behavior. 126. 108483–108483. 11 indexed citations

10.

Alsaadi, Taoufik, Manuel Toledo, Eugen Trinka, et al.. (2021). Perampanel Monotherapy in Epilepsy Patients with Focal and Generalized Seizures: Real-World Experience (1641). Neurology. 96(15_supplement).

11.

Flamini, Robert, Anna Patten, & Leock Y. Ngo. (2020). Long-term Safety and Efficacy of Adjunctive Perampanel in Pediatric Patients (Aged 4 to <12 years) with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) in Study 311 (413). Neurology. 94(15_supplement). 2 indexed citations

12.

Brandt, Christian, Robert Wechsler, Terence J. O’Brien, et al.. (2020). Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy. Seizure. 80. 115–123. 19 indexed citations

13.

Ngo, Leock Y., et al.. (2016). Naproxen sodium for pain control with intrauterine device insertion: a randomized controlled trial. Contraception. 94(4). 404–404. 2 indexed citations

14.

Altorjay, Áron, Éva Szabó, Z Boda, et al.. (2015). An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal. Thrombosis Research. 135(3). 485–491. 8 indexed citations

15.

Hahn, Angelika F., Said R. Beydoun, Victoria H. Lawson, et al.. (2013). A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy. Journal of the Peripheral Nervous System. 18(4). 321–330. 48 indexed citations

16.

Lum, Pek Yee, Leock Y. Ngo, Aimée H. Bakken, & Jashvant D. Unadkat. (2000). Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles. Cancer Chemotherapy and Pharmacology. 45(4). 273–278. 23 indexed citations

17.

Patil, Shivakumar D., Leock Y. Ngo, Paul Glue, & Jashvant D. Unadkat. (1998). Intestinal Absorption of Ribavirin Is Preferentially Mediated by the Na+-Nucleoside Purine (Nl) Transporter. Pharmaceutical Research. 15(6). 950–952. 72 indexed citations

18.

Ngo, Leock Y., et al.. (1997). Effects of Intravenous Infusion of Lidocaine on Its Pharmacokinetics in Conscious Instrumented Dogs. Journal of Pharmaceutical Sciences. 86(8). 944–952. 13 indexed citations

19.

Ngo, Leock Y., Y.K. Tam, & Ronald T. Coutts. (1995). Lack of residual effects of diethyl ether, methoxyflurane, and sodium pentobarbital on lidocaine metabolism in a single-pass isolated rat liver perfusion system.. Drug Metabolism and Disposition. 23(4). 525–528. 7 indexed citations

20.

Semple, Hugh A., Winston Koo, Y.K. Tam, Leock Y. Ngo, & Ronald T. Coutts. (1991). Interactions Between Hydralazine and Oral Nutrients in Humans. Therapeutic Drug Monitoring. 13(4). 304–308. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact